<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201511026776N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2015-12-24</date_registration>
      <primary_sponsor>Bojnourd University of Medical Sciences</primary_sponsor>
      <public_title>Impact of music therapy on anxiety and  pain of patient undergoing Extra corporeal Shock Wave Lithography</public_title>
      <acronym></acronym>
      <scientific_title>Impact of music therapy on pain and anxiety of patient undergoing Extra corporeal Shock Wave Lithography</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-11-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/7183</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Series of the random number equal to the half number of samples will be selected from a random numbers table.  If the random number will between 0 and 4, phrase AB and if between 5 and 9,  phrase BA will be written next to each other, then numbered and, according to the entry, the patients will be assigned into one of  groups, Blinding description: Headphone put on the ears of Participants in both music therapy and control groups. Music will only be played in music therapy groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Urinary stones.</hc_freetext>
      <i_freetext>Intervention 1: Music therapy: Before entering the ESWL room, the patient's anxiety will  measured by the visual analog scale, after transfer the patient on ESWL bed, blood pressure (systole and diastole and mean arterial blood pressure), heart rate and respiration rate, arterial oxygen saturation measured and recorded. The patient will given a position depending on the location of the urinary stones. By controlling with ultrasound, the focus of the device is adjusted to the stone. Before the procedure begins, the headphones are placed on the patient's head and the music starts playing. During the ESWL process, whenever the patient becomes restless or in the examination of a pain score of more than 7, the routine care of the center will be performed. In this case, the patient will be excluded from the study. With the start of the procedure, the pain is measured  every 10 minutes and at the end of the procedure with a numerical grading scale. The mean arterial pressure, heart rate and respiratory rate per minute, and arterial oxygen saturation are monitored at the beginning and then every 10 minutes at the end of the procedure. Anxiety is measured and recorded at the end of the procedure. Anxiety and pain measurement will be measured by a radiologist at the center. The total ESWL time, severity and number of shock, the total dose of the analgesic and anti-anxiety medication received, the length of the patient's stay in recovery will be recorded for each patient. Intervention 2: Control group: Music therapy: Before entering the ESWL room, the patient's anxiety will  measured by the visual analog scale, after transfer the patient on ESWL bed, blood pressure (systole and diastole and mean arterial blood pressure), heart rate and respiration rate, arterial oxygen saturation measured and recorded. The patient will given a position depending on the location of the urinary stones. By controlling with ultrasound, the focus of the device is adjusted to the stone.Before starting the procedure to cover the intervention, headphones are placed on the patient's head without music playing. During the ESWL process, whenever the patient becomes restless or in the examination of a pain score of more than 7, the routine care of the center will be performed. With the start of the procedure, the pain is measured  every 10 minutes and at the end of the procedure with a numerical grading scale. The mean arterial pressure, heart rate and respiratory rate per minute, and arterial oxygen saturation are monitored at the beginning and then every 10 minutes at the end of the procedure. Anxiety is measured and recorded at the end of the procedure. Anxiety and pain measurement will be measured by a radiologist at the center. The total ESWL time, severity and number of shock, the total dose of the analgesic and anti-anxiety medication received, the length of the patient's stay in recovery will be recorded for each patient.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Tooba Hoseini Azizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing, Shahyar Boulevard</address>
        <city>Bojnourd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9414635665</zip>
        <telephone>+98 58 3225 0358</telephone>
        <email>hoseini.tooba@gmail.com</email>
        <affiliation>North Khorasan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Tooba Hoseini Azizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing, Shahyar Boulevard</address>
        <city>Bojnourd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9414635665</zip>
        <telephone>+98 58 3225 0358</telephone>
        <email>hoseini.tooba@gmail.com</email>
        <affiliation>Bojnourd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>18-60 years old
Ability for reading and writing
Candidate for ESWL
No history of ESWL</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N20</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Calculus of kidney and ureter</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Music therapy: Before entering the ESWL room, the patient's anxiety will  measured by the visual analog scale, after transfer the patient on ESWL bed, blood pressure (systole and diastole and mean arterial blood pressure), heart rate and respiration rate, arterial oxygen saturation measured and recorded. The patient will given a position depending on the location of the urinary stones. By controlling with ultrasound, the focus of the device is adjusted to the stone. Before the procedure begins, the headphones are placed on the patient's head and the music starts playing. During the ESWL process, whenever the patient becomes restless or in the examination of a pain score of more than 7, the routine care of the center will be performed. In this case, the patient will be excluded from the study. With the start of the procedure, the pain is measured  every 10 minutes and at the end of the procedure with a numerical grading scale. The mean arterial pressure, heart rate and respiratory rate per minute, and arterial oxygen saturation are monitored at the beginning and then every 10 minutes at the end of the procedure. Anxiety is measured and recorded at the end of the procedure. Anxiety and pain measurement will be measured by a radiologist at the center. The total ESWL time, severity and number of shock, the total dose of the analgesic and anti-anxiety medication received, the length of the patient's stay in recovery will be recorded for each patient.</i_keyword>
      <i_keyword>Control group: Music therapy: Before entering the ESWL room, the patient's anxiety will  measured by the visual analog scale, after transfer the patient on ESWL bed, blood pressure (systole and diastole and mean arterial blood pressure), heart rate and respiration rate, arterial oxygen saturation measured and recorded. The patient will given a position depending on the location of the urinary stones. By controlling with ultrasound, the focus of the device is adjusted to the stone.Before starting the procedure to cover the intervention, headphones are placed on the patient's head without music playing. During the ESWL process, whenever the patient becomes restless or in the examination of a pain score of more than 7, the routine care of the center will be performed. With the start of the procedure, the pain is measured  every 10 minutes and at the end of the procedure with a numerical grading scale. The mean arterial pressure, heart rate and respiratory rate per minute, and arterial oxygen saturation are monitored at the beginning and then every 10 minutes at the end of the procedure. Anxiety is measured and recorded at the end of the procedure. Anxiety and pain measurement will be measured by a radiologist at the center. The total ESWL time, severity and number of shock, the total dose of the analgesic and anti-anxiety medication received, the length of the patient's stay in recovery will be recorded for each patient.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: Each 10 min during and after Procedure. Method of measurement: Numeric pain rating scale.</prim_outcome>
      <prim_outcome>Anxiety. Timepoint: Before and after procedure. Method of measurement: Anxiety numerical visual analogue scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Bojnourd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2015-10-05</approval_date>
        <contact_name>North Khorasan University of Medical Sciences</contact_name>
        <contact_address>North Khorasan Bojnourd North Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
